Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;66(11):1339-44.
doi: 10.1001/archneurol.2009.240.

Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons

Patricia A Boyle  1 , Aron S Buchman, Robert S Wilson, Sue E Leurgans, David A Bennett
Affiliations

Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons

Patricia A Boyle et al. Arch Neurol. 2009 Nov.

Abstract

Background: Loss of muscle strength is common and is associated with various adverse health outcomes in old age, but few studies have examined the association of muscle strength with the risk of Alzheimer disease (AD) or mild cognitive impairment (MCI).

Objective: To test the hypothesis that muscle strength is associated with incident AD and MCI.

Design: Prospective observational cohort study.

Setting: Retirement communities across the Chicago, Illinois, metropolitan area.

Participants: More than 900 community-based older persons without dementia at the baseline evaluation and in whom strength was measured in 9 muscle groups in arms and legs, and in the axial muscles and summarized into a composite measure of muscle strength.

Main outcome measures: Incident AD and MCI and the rate of change in global cognitive function.

Results: During a mean follow-up of 3.6 years, 138 persons developed AD. In a proportional hazards model adjusted for age, sex, and education status, each 1-U increase in muscle strength at baseline was associated with about a 43% decrease in the risk of AD (hazard ratio, 0.57; 95% confidence interval, 0.41-0.79). The association of muscle strength with AD persisted after adjustment for several covariates, including body mass index, physical activity, pulmonary function, vascular risk factors, vascular diseases, and apolipoprotein E4 status. In a mixed-effects model adjusted for age, sex, education status, and baseline level of global cognition, increased muscle strength was associated with a slower rate of decline in global cognitive function (P < .001). Muscle strength was associated with a decreased risk of MCI, the precursor to AD (hazard ratio, 0.67; 95% confidence interval, 0.54-0.84).

Conclusion: These findings suggest a link between muscle strength, AD, and cognitive decline in older persons.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative hazard of developing AD for participants with low (10th percentile, dotted line) versus high muscle strength (90th percentile, solid line).
Figure 2
Figure 2
Decline in global cognitive function for participants with low (10th percentile, dotted line) versus high muscle strength (90th percentile, solid line).
Figure 3
Figure 3
Risk of MCI for participants with low (10th percentile, dotted line) versus high muscle strength (90th percentile, solid line).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Scarmeas N, Albert M, Brandt J, Blacker D, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Wegesin D, Marder K, Bell K, Honig L, Stern Y. Motor signs predict poor outcomes in Alzheimer disease. Neurology. 2005;64:1696–1703. - PMC - PubMed
    1. Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC. Motor dysfunction in mildly demented AD individuals without extrapyramidal signs. Neurology. 1999;53:956–962. - PubMed
    1. Pettersson AD, Olsson E, Wahlund LO. Motor function in subjects with mild cognitive impairment and early Alzheimer’s disease. Dement Geriatr Cogn Disord. 2005;19(5–6):299–304. - PubMed
    1. Shin IS, Carter M, Masterman D, Fairbanks L, Cummings Jl. Neuropsychiatric symptoms and quality of life in Alzhiemer’s disease. Am J Geriatr Psychiatry. 2005;13(6):469–74. - PubMed
    1. Wilson RS, Schneider JA, Bienias JL, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology. 2003;61(8):1102–1107. - PubMed